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Abstract 
Rationale: The liver is a central organ not only for metabolism but also immune function. 
Life-threatening infections of both bacterial and fungal origin can affect liver function but it is yet unknown 
whether molecular changes differ depending on the pathogen. We aimed to determine whether the 
hepatic host response to bacterial and fungal infections differs in terms of hepatic metabolism and liver 
function. 
Methods: We compared murine models of infection, including bacterial peritoneal contamination and 
infection (PCI), intraperitoneal and systemic C. albicans infection, at 6 and 24 h post-infection, to sham 
controls. The molecular hepatic host response was investigated by the detection of regulatory modules 
based on large-scale protein-protein interaction networks and expression data. Topological analysis of 
these regulatory modules was used to reveal infection-specific biological processes and molecular 
mechanisms. Intravital microscopy and immunofluorescence microscopy were used to further analyze 
specific aspects of pathophysiology such as cholestasis. 
Results: Down-regulation of lipid catabolism and bile acid synthesis was observed after 6 h in all infection 
groups. Alterations in lipid catabolism were characterized by accumulation of long chain acylcarnitines 
and defective beta-oxidation, which affected metabolism by 6 h. While PCI led to an accumulation of 
unconjugated bile acids (BA), C. albicans infection caused accumulation of conjugated BA independent of 
the route of infection. Hepatic dye clearance and transporter expression revealed reduced hepatic 
uptake in fungal infections vs. defects in secretion following polybacterial infection. 
Conclusion: Molecular phenotypes of lipid accumulation and cholestasis allow differentiation between 
pathogens as well as routes of infection at early stages in mice. Targeted metabolomics could be a useful 
tool for the profiling of infected/septic patients and the type of pathogen, with subsequent customization 
and targeting of therapy. 
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Introduction 
Sepsis is differentiated from uncomplicated 
infection by a dysregulated host response leading to 
organ dysfunction which carries high morbidity and 
mortality. Sepsis is commonly triggered by bacterial 
or fungal pathogens, with predominant organisms 
including Staphylococcus aureus (20.5%), Pseudomonas 
species (19.9%), Enterobacteriacae (mainly E. coli, 
16.0%), and fungi (19%) [1]. Approximately 5-15% of 
nosocomial bloodstream infections are caused by 
invasive Candida strains, predominantly C. albicans [2, 
3]. In clinical practice, systemic infections are usually 
treated in the first instance as bacterial, with 
antifungal treatment commenced concurrently only in 
high-risk patients (e.g., immunosuppressed), or 
belatedly on laboratory isolation of a likely fungal 
pathogen. However, the risk of infection by 
opportunistic pathogens such as Candida increases 
after antibacterial therapy [4]. Furthermore, 
disruption of the balance of gut-associated microbial 
communities by antibiotic treatment can deplete 
microbiota-derived metabolites, thereby enhancing 
host susceptibility to pathogens and impairing 
immune homeostasis [5]. 
Bacteria and fungi are fundamentally different 
organisms. Bacteria, regardless of their Gram status, 
are prokaryotic organisms that grow rapidly and have 
a high rate of mutagenesis. Inadequate clearance of 
bacteria may lead to an overwhelmed host. Bacteria 
contain many constituents that can trigger a host 
immune response through activation of pathogen 
recognition receptors. For example, Gram negative 
bacteria activate a Toll-like receptor 4-dependent 
immune response via lipopolysaccharide (endotoxin), 
while Gram positive bacteria activate Toll-like 
receptor 2 and NOD-like receptors via peptidoglycan 
and lipoteichoic acid [6, 7].  
In contrast, Candida is a eukaryotic organism 
with gradual growth that is capable of growing as a 
unicellular yeast or as filamentous hyphae or 
pseudohyphae within its host [8]. It can colonize 
mucosal surfaces, but also grow invasively in tissue. 
Differential recognition of yeast and hyphal cells is 
considered key to the different immune responses 
elicited during colonization and invasion [9]. Various 
components of the outer and inner layer of the cell 
wall (e.g., mannans, glycoproteins, chitin, 
beta-glucan) can activate Toll-like receptors, C-type 
lectin reporters and NOD-like receptors to induce a 
host response [10, 11]. 
The liver plays a pivotal role in combating 
infection; its failure significantly worsens patient 
prognosis [12]. With its large number of macrophages 
(Kupffer cells), the liver represents the first line of 
defense against gut-derived pathogens due to 
drainage of the portal vein, the direct venous outflow 
from the intestine, into the liver [13]. In addition, it is a 
central metabolic organ. Beyond its synthetic capacity 
for secreted proteins and nutrition, including key 
proteins within the acute stress response, substances 
produced by the liver are absorbed by the gut and 
have a direct influence on the microbiota and barrier 
function. Obstruction of bile, for example, leads to 
microbial overgrowth, mucosal injury and, in some 
cases, translocation and systemic infection [14, 15]. 
This present work aims to elucidate differences in the 
metabolic host response to fungal and bacterial 
infection, and the effects of these infections on the 
host's liver function. 
Methods 
Animals 
Animal studies and protocols were approved by 
the animal welfare legislation of the state of 
Thuringia. Animals were housed under specific 
pathogen-free conditions, a 12 h day/night cycle and 
1 h dusk/dawn within the animal facility of the Jena 
University Hospital and the Hans-Knoell-Institute, 
Jena, Germany, with free access to food and water. 
During all invasive procedures and imaging methods, 
animals remained under deep general anesthesia. All 
surgical interventions were performed in a state of 
surgical tolerance of the animal in a semi-sterile 
environment using sterile equipment. 
Systemic polymicrobial and fungal infection 
Male, 17−20-week-old C57BL/6 mice were used 
for all infection models. For the polymicrobial sepsis 
model of PCI, mice were injected intraperitoneally 
with a microbiologically characterized human stool 
suspension [16] (1.2 μL/g body weight (BW)), which 
contains various aerobic and anaerobic gram-positive 
and gram-negative bacteria as well as trace amounts 
of C. albicans (Table S1). Candida albicans strains 
SC5314 and M137 (GFP expressing, for intravital 
microscopy) were used for fungal infection models. 
For candidemia (Ca i.v.), C. albicans was administered 
intravenously (2.5×104 colony forming units (CFU)/g 
BW); for Candida peritonitis (Ca i.p.), C. albicans was 
injected intraperitoneally (5×107 CFU/animal). 0.9% 
saline i.p. or i.v. was used for controls. At 6 or 24 h 
post-infection, animals were anesthetized, organs 
were harvested and plasma was processed 
immediately. Tissue and plasma were snap frozen in 
liquid nitrogen and stored at -80 °C. 
 Theranostics 2018, Vol. 8, Issue 14 
 
 
http://www.thno.org 
3768 
RNA isolation and microarray analysis 
Frozen liver tissue from the left median lobe was 
homogenized in lysis buffer from RNeasy Mini Kit 
(Qiagen, Hilden, Germany) with a pebble mill 
(QiaShredder, Qiagen) and further processed 
according to the manufacturer's instructions. RNA 
integrity was verified on the QIAxcel system 
(Qiagen). Total RNA was reversely transcribed and 
amplified using the TargetAmp-Nano Labeling Kit for 
Illumina Expression BeadChips (Epicentre, Madison, 
WI) according to the manufacturer's instructions. 
Samples were purified using the NucleoSpin RNA 
Clean-up system (Macherey-Nagel, Düren, Germany) 
and quantified using a NanoDrop spectrophotometer. 
Samples were hybridized on Illumina MouseRef-8-V2 
Expression BeadChips (Illumina, San Diego, CA). For 
posthybridization data read-out and data 
preprocessing, iScan Control Software was used. 
Control probe quality check was performed using 
Illumina Genome Studio-Software.  
Data pre-processing and analysis 
Microarray data were background adjusted and 
normalized; for data analysis self-organizing maps 
(SOMs) were computed. Miniclusters of co-regulated 
single genes are represented by metagenes that share 
functional context. These genes were then processed 
into an expression cartography that allows easy 
distinction of global processes. Identification of 
regulatory modules was performed using 
ModuleDiscoverer [17], which identifies protein 
communities in large-scale protein-protein interaction 
networks. For a detailed description see 
supplementary information.  
Metabolomics 
6-fold (w/v) ethanol-phosphate-buffer (15% 0.01 
M phosphate buffer solution pH 7.5, 85% ethanol) was 
added to pre-weighed liver tissue. Samples were 
homogenized in a pebble mill (QiaShredder) and 
centrifuged (5 min, 16000 ×g). The supernatant was 
used for quantification of 188 metabolites with the 
AbsoluteIDQ kit p180 (Biocrates Life Science AG, 
Innsbruck, Austria), as described [18]. Metabolite 
classes of amino acids and biogenic amines were 
quantified via LC-MS/MS; other metabolite groups 
were measured via flow injection analysis (FIA) and 
are considered semi-quantitative because standards 
were not available. Metabolite concentrations were 
log2 transformed and normalized to the mean of the 
control group. Further analysis was performed with 
the web-based tool MetaboAnalyst 3.0 [19]. Data were 
normalized by the autoscale method; one-way 
ANOVA with post-hoc Fisher's LSD test were used 
for statistical analysis. A heatmap with 
two-dimensional hierarchical clustering was 
performed using Euclidean distance and average 
algorithm. 
Quantification of bile acids 
Fifteen BA were determined in liver tissue 
lysates with an in-house assay. After protein 
precipitation and filtration, homogenized liver 
samples were loaded on an Agilent 1200 high 
performance liquid chromatography (LC) system 
(Agilent Technologies, Waldbronn, Germany) with a 
CTC-PAL autosampler coupled to an API 4000 Triple 
Quadrupole mass spectrometer with electrospray 
ionization source (AB Sciex, Darmstadt, Germany). 
All chromatographic separations were performed 
with a reverse-phase analytical column. The mobile 
phase consisted of water and methanol, both 
containing formic acid and ammonia acetate, at a total 
flow rate of 300 μL/min.  
Confocal intravital microscopy 
Intravital microscopy was performed after 
injection of amino-terminated DY-635 (Dyomics, Jena, 
Germany) (70 pmol/g BW) i.v. and fixing the liver ex 
situ on the stage of a LSM-780 microscope (Zeiss, 
Oberkochen, Germany), as described previously [20]. 
Fluorescence images were acquired every 5 min for 60 
min followed by a propidium iodide injection (i.v., 
100 pmol). Different wavelength settings are 
summarized in Table S2. The intensities of DY-635 
and NAD(P)H autofluorescence were quantified by a 
customized image analysis algorithm as the medians 
of the corresponding channels in each image 
computed over the tissue (hepatocytic) area (see 
Supplementary Material for details). The integrated 
DY-635 intensity was computed by averaging each 
time series.  
Multidrug resistance-associated protein 2 
(MRP2) staining 
Frozen tissue slices were formalin-fixed and 
stained with a rabbit polyclonal MRP2 antibody 
(M8316 Sigma Aldrich, 1:500), secondary AlexaFluor 
488 donkey anti-rabbit (Thermo Scientific, 1:1000), 
Alexa Fluor 568 conjugated Phalloidin (Thermo 
Scientific, 50 U/mL), mounted with VectaShield 
Mounting Media with DAPI (VectorLabs) and imaged 
on a confocal microscope (Zeiss LSM 780, see 
Supplementary Material for details). To quantify the 
MRP2 signal and its colocalization with F-Actin, the 
corresponding channels were segmented by a 
customized image analysis algorithm (see 
Supplementary Material for details). The areas of 
F-Actin and MRP2 positive regions were normalized 
by the total foreground (tissue) area. The overlap area 
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was computed as the number of double positive 
pixels normalized by the foreground area. 
Liver perfusion and transmission electron 
microscopy 
Mice were infected with bacteria or C. albicans as 
described above. At 6 or 24 h, mice were anesthetized 
and the liver was perfused via the portal vein with 
Krebs-Henseleit buffer (2 mL/min for 4 min) followed 
by perfusion with fixative (4% w/v formaldehyde, 
2.5% v/v glutaraldehyde in 100 mM sodium 
cacodylate buffer, pH 7.4) for 3 min. A slice from the 
center of the left median lobe was cut and placed in 
fixative for 24 h, then transferred to 100 mM sodium 
cacodylate buffer for intermediate storage. 
Preparation for transmission electron microscopy 
(TEM) was performed as described previously [21].  
Results 
To characterize the host response to bacterial and 
fungal infection, three different mouse models were 
used: a sepsis model of PCI for polymicrobial 
infection, and two Candida albicans infection models 
that differ in kinetics and pathogenesis for fungal 
infection. C. albicans injected intraperitoneally (Ca i.p.) 
leads to candida peritonitis whereas injected 
intravenously (Ca i.v.) leads to bloodstream infection 
and subsequent disseminated candidiasis [22, 23]. 
Since different pathogens and routes of infections 
were used, differences in disease progression and 
morbidity between groups cannot be completely 
eliminated. We addressed this by monitoring the 
hemogram, the phenotypical disease severity, and the 
pathogen load of each animal.  
A decrease in white blood cells was found in 
nearly all animals (Figure S1); however, mean 
corpuscular hemoglobin and mean corpuscular 
hemoglobin concentration increased more with C. 
albicans infection compared to polymicrobial sepsis. A 
noticeable variance was seen in platelet count in all 
groups.  
The score used by Gonnert et al. [16] was applied 
for phenotypical characterization and assessment of 
disease severity. PCI and Candida peritonitis led to 
early signs of illness at 6 h post-infection, whereas 
animals with candidemia still appeared clinically 
healthy. At 24 h post infection, both PCI and Ca i.v. 
had progressed to severe illness, while only some 
animals with Ca i.p. showed disease progression 
(Figure S2). 
Pathogen load assessed at 6 and 24 h (Figure S3) 
was in accordance with previous results [16]. At both 
time points, aerobic (Escherichia coli) and anaerobic 
(Bacteroides spp.) bacteria (for PCI) or C. albicans (for 
fungal infection models) were present in blood, liver, 
spleen, kidney, lung, and brain with differing 
amounts of CFU. After 6 h, bacteria, regardless of 
their classification, were present in similar 
concentrations. For Ca i.p., CFU were mainly found in 
the spleen after 6 and 24 h, followed by liver, kidney 
and lung. Low levels were found in blood and brain 
in some animals only. Ca i.v. resulted in equal 
numbers of CFU in the liver, spleen, kidney and lung 
at 6 h. CFU levels in blood were similar to Ca i.p. After 
24 h, CFU were predominantly found in kidney, 
followed by liver, spleen, lung and brain. Blood 
counts of C. albicans were low compared to other 
organs in all models.  
Hepatic transcriptional responses to Candida 
infection and polymicrobial sepsis show 
different patterns 
A transcriptomic approach was used to 
investigate the molecular hepatic host response to 
fungal and bacterial infection. Principal component 
analysis was applied to show general expression 
trends in the data. The first two principal components 
coincided with the time point of the sample (Figure 
1A). The different peritonitis insults at 6 h clustered 
closely together, whereas Ca i.v. at 6 h was located 
near the control samples. The corresponding animals 
did not show any sign of illness and had the lowest 
clinical severity score of 1 (Figure S2). At 24 h, two 
distinct subgroups were seen in the PCI animals that 
correlated with disease severity. Comparative 
transcriptomic analysis of liver microarrays was 
performed by SOM-analysis (Figure 1B). The 
strongest effects in liver tissue were the 
down-regulation of oxidation-reduction processes 
and lipid metabolism, both being more pronounced in 
the early phase. The acute phase response was 
upregulated in all infection models at both 
timepoints, as was the cellular response to 
interferon-gamma, which was more pronounced 24 h 
after infection. Additionally, intraperitoneal C. 
albicans infection produced a downregulation of gene 
clusters associated with protein translation, lipid 
metabolic processes, and membrane organization, 
whereas these genes were upregulated in the 
intravenous Candida infection model at 6 h. 
To analyze and characterize the cellular host 
response to infection on a molecular level, we 
identified regulatory modules. These modules are 
derived from known protein-protein-interaction 
networks, in conjunction with the information about 
differential expression from the microarray analysis 
(Figure 2). A regulatory module was computed for 
every model and route of infection independent of 
time. To observe infection-specific as well as common 
biological functions and pathways, we combined 
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modules corresponding to the same type of infection. 
This generated a comprehensive network of biological 
processes involved in fungal and bacterial infection 
(Figure 3A). Small unconnected subnetworks are 
omitted; the cytoscape session of the entire regulatory 
module can be found in Supplementary Material. 
 
 
Figure 1. Comparative transcriptomic profiling revealed downregulation of hepatic metabolism regardless of infection type. (A) Principal Component (PC) 
analysis of expression data. The first PC captures differences between control and treatment groups; Candida i.v. at 6 h is similar to control. The second PC captures differences 
between 6 and 24 h timepoints. Approximately 42% of the variation in the data was captured by the first two PCs. Numbers indicate the respective Clinical Severity Score (CSS) 
of the animal. (B) Self-organizing map (SOM) shows a global expression cartography of upregulated (red) and downregulated (blue) metagenes representing miniclusters of 
co-regulated single genes that share functional context. All groups showed early downregulation of metabolic processes. 
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Figure 2. Schematic workflow of Protein-Protein-Interaction Network 
analysis. (A) Regulatory modules were computed from microarray data for every 
model and time point individually. (B) All regulatory modules corresponding to the 
same model were combined to obtain a comprehensive network of biological 
processes. (C) Comparison of combined Candida modules to PCI modules resulted in 
the identification of proteins specific for PCI or Candida infection, respectively. 
 
Finally, to identify differences between fungal 
and polybacterial infection, we compared C. albicans 
networks to PCI networks. Nodes were selected that 
were specific for C. albicans, i.e., those present in all C. 
albicans regulatory modules with the exception of Ca 
i.v. 6 h due to its similarity to control, but which did 
not appear in any regulatory module of PCI. Only 3 
nodes were specific for C. albicans (enlarged 
sub-networks in Figure 3B, E). In contrast, 56 nodes 
were specific for polybacterial infection that did not 
appear in any C. albicans regulatory module. For 
example, PCI-specific nodes were found in the 
sub-networks associated with GeneOntology- 
category “immune system process” and “serine 
family amino acid metabolic process” (Figure 3C), 
“steroid biosynthetic process” (Figure 3D), and 
“small molecule metabolic processes” (Figure 3E). 
The latter two were of particular interest as they 
involve oxoacid metabolic processes, fatty acid 
beta-oxidation, and sterol- and lipid biosynthetic 
processes. These sub-networks depict effects in detail 
that were also seen as being overall down-regulated 
in the SOM analysis (Figure 1B) and which have a 
pivotal role for liver function. Since both subnetworks 
contain PCI-specific nodes, we hypothesized that the 
respective biological processes would also show 
differences at a functional level. Thus, we further 
investigated these biological processes to assess 
physiological consequences of the alteration in 
hepatic metabolism. 
Hepatic lipid metabolism is dysregulated in C. 
albicans and polymicrobial infection 
Since hypometabolism was very pronounced in 
transcriptomic data of all infection models, we 
investigated the metabolic profile from liver tissue 
lysates. The metabolome was evaluated by 
simultaneous detection and quantification of 188 
metabolites via mass spectrometry. Of these, 180 
metabolites were successfully detected and analyzed 
statistically, with 131 differing significantly from 
control or other infection groups. The metabolites 
were grouped into six different classes: acylcarnitines, 
amino acids, biogenic amines, glycerophospholipids, 
sphingolipids and sugars. Within these classes, 
different effects were observed for each infection 
model and timepoint compared to control (Table 1). 
In addition to the statistical analysis, an unsupervised 
hierarchical clustering was performed and visualized 
in a heat map, with a dendrogram showing the top 
100 significant metabolites, including metabolites 
until p=0.009 (Figure S4). Acylcarnitines, amino acids 
and glycerophospholipids were dominated by kinetic 
effects with an increased percentage of differentially 
regulated metabolites from 6 h to 24 h (Table 1). Ten 
of the 21 measured amino acids significantly differed 
in Ca i.v. 24 h compared to control, with most being 
lower, in particular serine. Protein-protein-interaction 
network analysis also showed a cluster associated 
with “serine family amino acid metabolic process”, 
with several nodes specific for PCI (Figure 3A). 
However, the statistical significance of amino acids 
was low compared to other metabolites and 
expression levels of the corresponding genes were 
similar for Ca i.v. and PCI at 24 h.  
Profound changes were observed within the 
acylcarnitine group, particularly at 24 h 
post-infection. For PCI and Ca i.p., this amounted to 
55% and 52.5% of significant metabolites, and 37.5% 
for Ca i.v. As carnitines and acylcarnitines are 
essential compounds in fatty acid catabolism, these 
were studied in more detail in conjunction with the 
transcriptomic analysis. 
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Figure 3. Identified regulatory network highlighting clusters of proteins with similar function. (A) Combined protein-protein-interaction networks from all 
treatment groups. The corresponding GO-category biological process is color-coded. Nodes that occur exclusively in PCI are outlined in black, nodes specific for 
Candida-infection are outlined in red. (B) Enlarged network associated with GO-term “response to ER-stress”. (C) Enlarged network associated with GO-term “serine family 
amino acid metabolic process”. (D) Enlarged network associated with GO-term “steroid biosynthetic process”. (E) Enlarged network associated with GO-term “small molecule 
metabolic process”.  
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Table 1. Metabolite groups differ significantly between time and treatment. Metabolites were measured in liver tissue; all 
infection groups and timepoints were compared to control. Number and percent of significantly different metabolites are displayed for the 
respective metabolite group (ANOVA, Fisher's LSD, p-value < 0.05). 
 PCI 6 h PCI 24 h Ca ip 6 h Ca ip 24 h Ca iv 6 h Ca iv 24 h 
acylcarnitines 13 (32.5%) 22 (55.0%) 6 (15.0%)  21 (52.5%) 3 (7.5%) 15 (37.5%) 
amino acids 1 (4.8%) 4 (19.0%) 1 (4.8%) 2 (9.5%) 0 (0.0%) 10 (47.6%) 
biogenic amines 6 (46.2%) 6 (46.2%) 8 (61.5%) 4 (30.8%) 4 (30.8%) 8 (61.5%) 
glycerophospho-lipids 24 (26.7%) 45 (50.0%) 13 (14.4%) 47 (52.2%) 16 (17.8%) 47 (52.2%) 
sphingolipids 4 (26.7%) 6 (40.0%) 8 (53.3%) 6 (40.0%) 5 (33.3%) 6 (40.0%) 
sugar/hexose 1 (100%) 1 (100%) 1 (100%) 1 (100%) 0 (0.0%) 1 (100%) 
 
As illustrated in Figure 4A, fatty acids must be 
activated through acyl-Coenzyme A (CoA) synthase 
before their entry into the mitochondria. Medium- 
and long-chain-fatty acids require active transport via 
the carnitine shuttle. Inside the mitochondria, 
acyl-CoA is degraded via beta-oxidation and 
subsequently contributes to adenosine triphosphate 
production via cleavage of acetyl CoA and production 
of NADH and FADH2. Transcriptomic data revealed 
downregulation of the majority of corresponding 
genes (Figure 4B). A heat map shows the scaled 
relative changes between groups within this 
downregulation; most of the downregulation was 
seen in PCI at 6 h and Ca iv at 24 h. At the protein 
level, metabolomics showed a pronounced 
accumulation of different acylcarnitine chain lengths, 
as classified by Ikeda et al. [24] (Figure 4C). Compared 
to control, the amount of long-chain acylcarnitines 
was significantly increased in PCI at 6 h and 24 h, and 
in Ca i.p. and Ca i.v. at 24 h. While medium-chain 
acylcarnitines did not show a large effect, the amount 
of short-chain acylcarnitines was increased in PCI at 
24 h, but decreased in Ca i.p. at 6 h. An accumulation 
of free carnitine was also seen in all groups at 24 h 
(Figure S4). This suggests an ineffective carnitine 
shuttle but does not explain why medium-chain 
acylcarnitines do not accumulate. More likely, the first 
step of β-oxidation, which is catalyzed by 
acyl-CoA-dehydrogenases, was affected. Acyl-CoA- 
dehydrogenases show different specificities for short-, 
medium- or long-chain fatty acid acyl-CoA substrates; 
accumulation of long-chain-acylcarnitines hints at 
defects in the enzyme specific for long and very long 
acylcarnitines. The effects on energy metabolism were 
visible by a decrease of NAD(P)H autofluorescence in 
liver tissue in vivo (Figure 4D). 
The defective lipid degradation had a severe 
impact on morphology since non-degraded lipids 
were stored within accumulating vesicles as seen by 
TEM and Sudan-3 staining (Figure 4E-F). Lipid 
droplets were observed 6 h post-infection, suggesting 
impaired degradation but increased shuttling and 
uptake. Of note, in all models lipids accumulated in 
vesicles but with very distinct features for the 
different models. At 6 h, a heterogeneous 
damage-pattern was seen in liver tissue that differed 
not only between individuals but also between 
microanatomical sites and the respective level of 
oxygenation. While the size of vesicles was 
comparable between perivenous and periportal 
zones, the number of vesicles was considerably higher 
at sites of low oxygen concentrations near the central 
vein (Figure S5). Perivenous regions of PCI at 6 h 
showed vesicles that were similar in size to the 
control, but significantly greater in number. 
At 24 h, a more homogeneous and distinct 
pattern of vesicle accumulation was noted (Figure 
4E). Vesicle counts had lower variance and similar 
numbers at the anatomical sites were observed. An 
exception was Ca i.p., where the perivenous amount 
was noticeably higher, though possibly 
counterbalanced by a greater periportal vesicle 
perimeter (Figure S5). In PCI livers, cells were filled 
with large vesicles at 24 h. Cell-cell-junctions were 
partly disrupted and bile canaliculi had less or no 
microvilli (data not shown). Ca i.v. at 24 h resulted in 
medium-sized vesicles that appeared darker under 
TEM. Ca i.p. also produced medium-sized vesicles 
that were distinctly located at the cell borders. 
Canalicular brush borders and cell-cell-connectivity 
did not appear to be affected by Ca i.p. or i.v. 
infection. 
C. albicans infection leads to early conjugation 
and excretion failure 
Changes in sterol and lipid biosynthetic 
processes were observed in microarray and 
protein-protein-interaction network analysis; 
consequently, we investigated changes in the 
biotransformation of endobiotics in the liver during 
fungal and polymicrobial infection. As depicted in 
Figure 5A, BA are processed in an enterohepatic cycle. 
They are produced in hepatocytes, and are conjugated 
to taurine and subsequently secreted into the bile, 
where they enter the gut. 
Transcriptomic data showed that the majority of 
genes associated with primary bile synthesis were 
downregulated (Figure 5B). The heatmap of the 
associated genes showed the scaled relative changes 
between groups within this downregulation. It 
revealed that the downregulation was most 
pronounced for PCI 6 h. 
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Figure 4. Transcriptomics, metabolomics and microscopy revealed defects in lipid metabolism. (A) Schematic outline of fatty acid activation, transport and 
metabolism. Corresponding genes from the interaction network are depicted. (B) Genes involved in fatty acid degradation are overall downregulated; genes that are up- or 
downregulated in all groups are marked by a red or green gene symbol. A heat map shows the scaled relative changes within the downregulation. (C) Distribution of different 
acylcarnitine chain-length for all groups and timepoints. Values shown as Log2FC of the sum of short-chain (C2-C8), medium-chain (C6-C10) and long-chain (C14-C22) 
acylcarnitines, as classified by Ikeda et al. [24] (D) Effects on energy metabolism are depicted by NAD(P)H fluorescence in liver tissue at the first timepoint using time-lapse 
intravital imaging. Subgroups are separated by the respective clinical severity score (CSS) of the animals. (E) Representative electron micrographs demonstrating a morphologic 
assessment of liver ultrastructure. Pathogen and route of infection leads to different patterns of lipid accumulation. 3000x magnification (Nucleus (N), mitochondria (M), vesicles 
(V)). (F) Sudan III-staining of representative histological sections of murine liver depict tissue and lipid accumulation after PCI and C. albicans infection. 
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Figure 5. Bile acid synthesis, conjugation and secretion are distinct for PCI and Candida infection. (A) Schematic outline of bile synthesis, conjugation and export. 
CA: cholic acid; CDCA: chenodeoxycholic acid; DCA: deoxycholic acid; LCA: lithocholic acid; GCA: glycocholic acid; TCA: taurocholic acid; TCDCA: taurochenodeoxycholic 
acid; TDCA: taurodeoxycholic acid; TLCA: taurolithocholic acid; TUDCA: tauroursodeoxycholic acid; BAAT: bile acid-CoA:amino acid n-acyltransferase. (B) Genes involved in 
primary bile synthesis are overall downregulated; genes downregulated in all groups are marked by a green gene symbol. A heat map shows scaled relative changes within the 
downregulation. (C) Relative change in conjugated and unconjugated bile acids and (D) respective conjugation index of bile acids. (E) Immunostaining of MRP2 in liver tissue 
(white). MRP2 is localized at the cell membrane and linked to the cytoskeleton (F-actin, purple). (F) Quantification of MRP2-stained areas and overlap areas with F-actin (Figure 
S6) at 20x magnification depict the loss of membrane-associated MRP2 protein leading to cholestasis. 
 
Metabolic analysis of unconjugated and 
conjugated BA via mass spectrometry revealed 
differences in biotransformation and bile uptake 
(Figure 5C-D). Bacterial sepsis led to an accumulation 
of unconjugated BA, as indicated by the negative 
conjugation index compared to control. In contrast, an 
increase in conjugated bile acid concentration was 
observed with fungal infections. Formation of 
unconjugated BA from sterols are catalyzed by bile 
acid-CoA thioesterases, while conjugation with 
taurine or glycine is facilitated by bile 
acid-CoA:amino acid N-acyltransferases. Both 
reactions take place in peroxisomes (primary BA) and 
cytosol (secondary BA). Conjugation facilitates 
secretion into bile [25], lowers the acid dissociation 
constant and thereby prevents their precipitation 
within the upper intestinal environment. This enables 
BA to act as a detergent for dietary lipids within the 
intestine and to detoxify hydrophobic BA. Hence, 
accumulation of unconjugated BA may become 
hepatotoxic.  
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Besides impaired conjugation, the uptake and 
excretion of BA into hepatic canaliculi present further 
steps in the biotransformation that can lead to 
cholestasis when impaired. We therefore analyzed the 
membrane localization of MRP2, a 
canalicular transporter for BA and 
bilirubin-conjugates. Although no 
significant changes were observed at 
the transcriptional level, MRP2 was 
reduced (Figure 5E-F). 
To elucidate the extent uptake and 
excretion were impaired, clearance of 
DY-635, a dye taken up and secreted by 
hepatocytes into the bile, was 
investigated using time-lapse confocal 
intravital microscopy (Figure 6). The 
resulting images were assessed by 
visual interpretation of anatomical 
structures, and dye accumulation was 
quantified via automated image 
analysis by integrating DY-635 
intensities over time. Since DY-635 
massively diffuses and accumulates 
within cells without an intact cell 
membrane, these areas were excluded 
as outliers by computing the median of 
the DY-635 intensity in the tissue in 
each field of view. The accumulation of 
DY-635 in hepatocytes in polymicrobial 
sepsis at 24 h was evident both from an 
increase of integrated fluorescence 
intensity and from visual inspection of 
images, where no obvious excretion 
into bile ducts was observed. In both 
C. albicans infection models, an initial 
decrease in hepatocyte DY-635 
fluorescence was observed. At the 
sinusoidal-hepatic interface there was 
accumulation of dye at the borders of 
the hepatocytes, indicating decreased 
dye uptake. However, at 24 h an 
increase in DY-635 fluorescence was 
also observed in C. albicans infection 
models. 
Thus, C. albicans infection resulted 
in an initial pre-hepatic accumulation of 
xenobiotics and predominantly, but not 
exclusively, glycine-conjugated BA. The 
depicted pattern of the metabolomic 
profile and intravital microscopic 
observation during polymicrobial 
sepsis, by contrast, showed early 
conjugation and excretion failure in 
hepatocytes leading to an intrahepatic 
accumulation of endo- and xenobiotics 
with subsequent cholestatic manifes-
tations. Within the time course of the 
 
 
Figure 6. Intravital microscopy shows early pre-hepatic dysfunction for C. albicans infection. 
Murine liver tissue is depicted by NAD(P)H autofluorescence (blue); DY-635 accumulation and excretion are 
depicted 60 min after injection (yellow). Scale bars = 100 µm. Stars indicate dead cells (verified by 
post-experimental propidium iodide staining); arrowheads indicate pre-hepatic dye accumulation. Intensities 
of DY-635 were analyzed by a customized image analysis algorithm. Tissue DY-635 signal was integrated over 
60 min to assess liver function by means of DY-635 uptake and elimination. Subgroups are separated by their 
respective clinical severity score (CSS). 
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study, this initial accumulation of conjugated BA 
appeared to be overwhelmed by hepatic damage 
caused by the fungus, with subsequent fulminant 
hepatic excretory failure. 
Discussion 
Excretory dysfunction and jaundice reflect poor 
prognostic events in patients presenting with 
infection. For liver cirrhosis, differing levels of plasma 
lipids and lipoproteins can distinguish etiology, e.g., 
alcoholic or viral origin [26]. Severity of cirrhosis can 
also be monitored by serum metabolomics [27]. 
Similarly, different stages of liver fibrosis can be 
distinguished by their metabolomic fingerprint [28].  
Little is known about the metabolomic 
phenotype of the host response to infection, in 
particular depending on different pathogens. 
Previously observed transcriptomic changes in 
comparable models of invasive Candida infections 
were dominated by a strong induction of the innate 
immune response [29]. In our study, we observed 
similar effects, as well as a significant reduction in 
overall metabolic activity and downregulation of 
oxidation-reduction processes with disease 
progression. Metabolic changes during sepsis have 
been discussed in recent reviews [30]. For instance, it 
has been shown in a rat model of sepsis with 
survivor/non-survivor-discrimination that predicted 
non-survivors displayed strong downregulation of 
fatty acid metabolism, amino acid metabolism and 
bile acid synthesis already after 6 h when compared to 
naïve or sham-treated animals, whereas predicted 
survivors showed less or no downregulation. Hence, 
the severity of the metabolic changes is related to 
outcome [21]. In these studies phosphatidylinositol 
3-kinase-dependent signaling was proposed as crucial 
mediator of liver dysfunction and metabolic changes 
between predicted survivors and non-survivors. 
Regardless of the underlying signaling, many of the 
altered metabolite classes might affect the course of 
infection themselves (e.g., fatty acids, bile acids). 
In conjunction with the literature, we observed 
changes in fatty acid metabolism, especially an 
increase of long chain acylcarnitines, leading to early 
deficits in energy metabolism and accumulation of 
lipid vesicles within hepatocytes. Fatty acid 
metabolism and other metabolic processes follow the 
oxygen gradient along the porto-central axis. Fatty 
acid oxidation takes place at higher rates in periportal 
hepatocytes, where oxygen concentration is higher 
[31]. Katz et al. [32] reported higher activity of 
carnitine palmitoyltransferase-1, a key enzyme of the 
carnitine shuttle. The cytoplasmic fatty-acid-binding 
protein 1, which is involved in intracellular lipid 
transport, is also increased in the periportal zones [33, 
34]. This suggests a higher uptake and utilization of 
fatty acids by periportal hepatocytes. In contrast, 
perivenous hepatocytes show both higher activities 
and a greater presence of the lipogenic enzymes 
acetyl-CoA carboxylase and adenosine triphosphate 
citrate lyase [32], as well as higher rates of very low 
density lipoprotein synthesis [35]. In the early phase 
of infection, there was major accumulation of lipid 
vesicles, predominantly in perivenous areas. Thus, 
cells that show lower rates of fatty acid oxidation may 
be easily affected by imbalances in lipid homeostasis 
with fatty acid synthesis upregulated in turn. Similar 
patterns of lipid accumulation were described in a rat 
model of alcoholic fatty liver disease, where ethanol 
feeding caused a selective deposition of triglycerides 
and reduced very low density lipoprotein secretion in 
pericentral hepatocytes [36].  
After 24 h, lipid accumulation and damage 
appeared to be independent from liver zonation and it 
became a global phenomenon. Different patterns of 
lipid deposition were seen between C. albicans 
infection models and the polymicrobial sepsis model. 
Accumulation of lipid vesicles may have various 
causes. Increased influx of fatty acid may be due to an 
increase in free fatty acids related to increased 
lipolysis. Decreased efflux of fatty acids can also occur 
if β-oxidation is decreased and/or very low density 
lipoprotein transport is disturbed. As indicated by the 
metabolomic and transcriptomic analyses, lipid 
accumulation is likely driven by defective 
β-oxidation. Differential deposition pattern of lipid 
droplets may be influenced by the differing 
expression of apolipoproteins and phosphatidyl-
cholines. Both enable very low density lipoprotein 
assembly and secretion and could facilitate 
compensatory mechanisms in Candida models. The 
type of accumulating lipids may also play a central 
role for disease progression, as triglycerides are 
discussed to be counter protection against lipid 
induced toxicity, whereas free fatty acids may be 
important mediators of toxicity [37]. 
During severe infection, defective β-oxidation, 
which might occur in oxygen rich zones of the liver, 
may be a key feature. Due to inadequate oxygen 
supply to the liver during sepsis, liver zonation is 
shifted towards low oxygen zones, or even lost 
completely [38]. A long-term septic model in rats 
showed an early decline in tissue oxygenation 
especially in the liver, the degree of which related to 
poor prognosis [39]. A shift in liver zonation also 
implicates a shift of metabolic zones, reducing fatty 
acid oxidation in favor of lipo- and ketogenesis. This 
may happen due to reduced perfusion or an 
imbalance of the corresponding signaling pathways of 
HIF1α and β-catenin, which have been shown to be 
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responsible for maintenance of the complex liver 
zonation and functional organization [31, 40]. 
Our data also depict different patterns of liver 
dysfunction depending on the pathogen, and the 
route of infection in the case of Candida infection. 
Unconjugated BA accumulated in polybacterial sepsis 
whereas C. albicans infection led to an accumulation of 
conjugated BA. C. albicans infection also caused 
accumulation of the hepatic-eliminated dye DY-635 at 
the basolateral pole of the hepatocytes within the 
sinusoids, indicating a basolateral liver dysfunction.  
BA are increased in plasma of patients with 
critical illnesses [41]. In contrast to our data, human 
post-mortem liver biopsies from septic patients 
showed elevated levels of conjugated BA, although 
the underlying pathogen was not determined [42]. 
Besides a differential expression of bile transporters, 
other mechanisms influence the obstruction of BA. 
For instance, a loss of contractile activity in actin and 
myosin microfilaments leads to reduced transport of 
BA through the canalicular route [43, 44]. This 
subsequently leads to bile ducts paralysis, distension, 
and bile secretory failure observed in septic shock 
patients and after long-term treatment in the intensive 
care unit, and is associated with severe morbidity [45, 
46]. In an animal model, fasting during the course of 
illness induced a shift from unconjugated to 
conjugated circulating BA [47].  
Bile acids are known to be cytotoxic, they can 
induce apoptosis and necrosis by damage to 
mitochondria [48, 49], and they are also 
danger-associated molecular patterns (DAMPs) that 
activate inflammatory macrophages [50]. The 
importance of BA for the control of the intestinal 
microbiome was recently highlighted [51]. 
Obstruction of BA due to liver failure and chronic 
infection may contribute to chronic gut barrier failure 
and impaired regeneration by the host and, in turn, 
enable translocation of microorganisms and 
secondary infections. 
The present study elucidates differences and 
similarities of the hepatic host response to different 
pathogens. Molecular phenotypes allowed clear 
differentiation between polymicrobial and fungal 
infection, already at an early stage. Early differences 
in metabolites, lipid accumulation and liver failure 
characterized by heterogeneous liver damage have 
also been demonstrated in this study, suggesting the 
need for a broader assessment of hepatic metabolism. 
Specific metabolites are altered in septic patients and 
were recently employed to distinguish inflammatory 
response, route of infection and outcome despite the 
heterogeneity of this patient group [18, 52]. An 
Increase in acylcarnitines could be measured in 
samples of septic non-survivors [53-55], whereas a 
rise of linoleic acid was associated with effective 
treatment [56]. Nevertheless, patients with fungal 
infections were not included in these studies. This is a 
challenging clinical need but of increasing interest in 
the light of precision medicine during systemic 
infections of different origin. Targeted metabolomics 
are an emerging field and can be used to diagnose or 
assess stages and severity of different liver diseases 
such as cirrhosis [26, 27] and fibrosis [28]. We herein 
demonstrate that liver pathophysiology leads to 
distinct metabolomic fingerprint in sepsis due to the 
type and route of the pathogen and could be a useful 
tool for profiling of patients and subsequent 
customization and targeting of therapy. 
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